Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | CHSY3 | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Chsy3 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CHSY3 mRNA | CTD | PMID:36331819 | CHSY3 | Human | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Progesterone] results in increased expression of CHSY3 mRNA | CTD | PMID:20660070 | CHSY3 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Chsy3 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CHSY3 mRNA | CTD | PMID:19770486 | CHSY3 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Chsy3 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CHSY3 mRNA | CTD | PMID:32109520 | CHSY3 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Chsy3 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CHSY3 mRNA | CTD | PMID:26290441 | CHSY3 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Chsy3 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CHSY3 mRNA | CTD | PMID:22298810 | CHSY3 | Human | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | ISO | Chsy3 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:32109520 | CHSY3 | Human | 4,4'-sulfonyldiphenol | increases expression | ISO | Chsy3 (Mus musculus) | 6480464 | bisphenol S results in increased expression of CHSY3 mRNA | CTD | PMID:30951980 | CHSY3 | Human | 4,4'-sulfonyldiphenol | decreases methylation | EXP | | 6480464 | bisphenol S results in decreased methylation of CHSY3 gene | CTD | PMID:31601247 | CHSY3 | Human | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of CHSY3 mRNA | CTD | PMID:33212167 | CHSY3 | Human | benzo[a]pyrene | increases mutagenesis | EXP | | 6480464 | Benzo(a)pyrene results in increased mutagenesis of CHSY3 gene | CTD | PMID:25435355 | CHSY3 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of CHSY3 promoter | CTD | PMID:27901495 | CHSY3 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of CHSY3 exon | CTD | PMID:27901495 | CHSY3 | Human | benzo[a]pyrene | decreases expression | ISO | Chsy3 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of CHSY3 mRNA | CTD | PMID:19770486 | CHSY3 | Human | bisphenol A | decreases expression | ISO | Chsy3 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of CHSY3 mRNA | CTD | PMID:25181051 | CHSY3 | Human | bisphenol A | decreases methylation | EXP | | 6480464 | bisphenol A results in decreased methylation of CHSY3 gene | CTD | PMID:31601247 | CHSY3 | Human | bisphenol A | increases expression | ISO | Chsy3 (Mus musculus) | 6480464 | bisphenol A results in increased expression of CHSY3 mRNA | CTD | PMID:30951980 and PMID:34585602 | CHSY3 | Human | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CHSY3 mRNA and bisphenol A results in decreased expression of CHSY3 protein | CTD | PMID:29275510 and PMID:33376534 | CHSY3 | Human | bisphenol F | increases expression | ISO | Chsy3 (Mus musculus) | 6480464 | bisphenol F results in increased expression of CHSY3 mRNA | CTD | PMID:38685157 | CHSY3 | Human | butanal | decreases expression | EXP | | 6480464 | butyraldehyde results in decreased expression of CHSY3 mRNA | CTD | PMID:26079696 | CHSY3 | Human | carbon nanotube | increases expression | ISO | Chsy3 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | CHSY3 | Human | chlorpyrifos | decreases expression | ISO | Chsy3 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of CHSY3 mRNA | CTD | PMID:37019170 | CHSY3 | Human | choline | multiple interactions | ISO | Chsy3 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CHSY3 gene | CTD | PMID:20938992 | CHSY3 | Human | cisplatin | decreases expression | ISO | Chsy3 (Rattus norvegicus) | 6480464 | Cisplatin results in decreased expression of CHSY3 mRNA | CTD | PMID:22023808 | CHSY3 | Human | dioxygen | multiple interactions | ISO | Chsy3 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CHSY3 mRNA | CTD | PMID:30529165 | CHSY3 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHSY3 mRNA | CTD | PMID:27188386 | CHSY3 | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of CHSY3 mRNA | CTD | PMID:29803840 | CHSY3 | Human | endosulfan | decreases expression | ISO | Chsy3 (Rattus norvegicus) | 6480464 | Endosulfan results in decreased expression of CHSY3 mRNA | CTD | PMID:29391264 | CHSY3 | Human | folic acid | multiple interactions | ISO | Chsy3 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CHSY3 gene | CTD | PMID:20938992 | CHSY3 | Human | L-methionine | multiple interactions | ISO | Chsy3 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CHSY3 gene | CTD | PMID:20938992 | CHSY3 | Human | lipopolysaccharide | multiple interactions | EXP | | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of CHSY3 mRNA | CTD | PMID:35811015 | CHSY3 | Human | N-nitrosodiethylamine | increases expression | ISO | Chsy3 (Mus musculus) | 6480464 | Diethylnitrosamine results in increased expression of CHSY3 mRNA | CTD | PMID:24535843 | CHSY3 | Human | paracetamol | affects expression | ISO | Chsy3 (Mus musculus) | 6480464 | Acetaminophen affects the expression of CHSY3 mRNA | CTD | PMID:17562736 | CHSY3 | Human | paracetamol | increases expression | ISO | Chsy3 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of CHSY3 mRNA | CTD | PMID:33387578 | CHSY3 | Human | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of CHSY3 mRNA | CTD | PMID:29067470 | CHSY3 | Human | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of CHSY3 mRNA | CTD | PMID:26690555 | CHSY3 | Human | paraquat | decreases expression | ISO | Chsy3 (Rattus norvegicus) | 6480464 | Paraquat results in decreased expression of CHSY3 mRNA | CTD | PMID:32680482 | CHSY3 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Chsy3 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CHSY3 mRNA | CTD | PMID:36331819 | CHSY3 | Human | progesterone | increases expression | EXP | | 6480464 | Progesterone results in increased expression of CHSY3 mRNA | CTD | PMID:20864642 | CHSY3 | Human | progesterone | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Progesterone] results in increased expression of CHSY3 mRNA | CTD | PMID:20660070 | CHSY3 | Human | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | EXP | | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of CHSY3 mRNA | CTD | PMID:35811015 | CHSY3 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHSY3 mRNA | CTD | PMID:27188386 | CHSY3 | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of CHSY3 mRNA | CTD | PMID:25879800 | CHSY3 | Human | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of CHSY3 mRNA | CTD | PMID:31533062 | CHSY3 | Human | temozolomide | increases expression | EXP | | 6480464 | Temozolomide results in increased expression of CHSY3 mRNA | CTD | PMID:31758290 | CHSY3 | Human | tetrachloromethane | increases expression | ISO | Chsy3 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of CHSY3 mRNA | CTD | PMID:31919559 | CHSY3 | Human | thioacetamide | increases expression | ISO | Chsy3 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of CHSY3 mRNA | CTD | PMID:34492290 | CHSY3 | Human | titanium dioxide | decreases methylation | ISO | Chsy3 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of CHSY3 gene and titanium dioxide results in decreased methylation of CHSY3 promoter | CTD | PMID:35295148 | CHSY3 | Human | trichloroethene | increases expression | ISO | Chsy3 (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased expression of CHSY3 mRNA | CTD | PMID:33387578 | CHSY3 | Human | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of CHSY3 mRNA | CTD | PMID:24935251 | CHSY3 | Human | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of CHSY3 gene | CTD | PMID:29154799 | CHSY3 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of CHSY3 mRNA | CTD | PMID:25979313 | CHSY3 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of CHSY3 mRNA | CTD | PMID:23179753 more ... | CHSY3 | Human | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHSY3 mRNA | CTD | PMID:27188386 | |